Eris Lifesciences Limited
Promoter holding in Eris Lifesciences Limited was 54.74% in Sep 2026, up 0.60 points from the previous quarter. Since Dec 2024 it has fallen 0.12 points.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Sep '26 | 54.74%▲0.60 | 45.26%▼0.60 |
| Jun '26 | 54.14%▲0.22 | 45.86%▼0.22 |
| Mar '26 | 53.92%▼0.93 | 46.08%▲0.93 |
| Dec '25 | 54.85%=0.00 | 45.15%=0.00 |
| Sep '25 | 54.85%▲0.02 | 45.15%▼0.02 |
| Jun '25 | 54.83%▼0.02 | 45.17%▲0.02 |
| Mar '25 | 54.85%▼0.01 | 45.15%▲0.01 |
| Dec '24 | 54.86%▼0.01 | 45.14%▲0.01 |
Trend
- Over a longer period, promoter holding went from 52.68% in Sep 2021 to 54.74% in Sep 2026, up 2.06 points.
- Of the last 8 quarterly changes on record, promoter holding rose in 3, fell in 4 and stayed the same in 1.
- The largest quarterly change was a fall of 0.93 points in the quarter to Mar 2026.
Compared with similar companies
Promoter holding in Eris Lifesciences Limited is higher than 52% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Eris Lifesciences Limited | 54.74% |
| Alivus Life Sciences Limited | 74.87% |
| Alembic Pharmaceuticals Limited | 69.87% |
| OneSource Specialty Pharma Limited | 30.48% |
| AstraZeneca Pharma India Limited | 75.00% |
| Syngene International Limited | 52.59% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Eris Lifesciences Limited's promoter holding?
Promoters held 54.74% of Eris Lifesciences Limited as of 30 Sep 2026, and the public held 45.26%.
Has Eris Lifesciences Limited's promoter holding increased?
Yes, it rose by 0.60 percentage points in the quarter to Sep 2026.
Are any promoter shares of Eris Lifesciences Limited pledged?
No promoter shares are recorded as pledged.
How has Eris Lifesciences Limited's promoter holding changed over the years?
Over a longer period, promoter holding went from 52.68% in Sep 2021 to 54.74% in Sep 2026, up 2.06 points.
How does Eris Lifesciences Limited's promoter holding compare with similar companies?
Promoter holding in Eris Lifesciences Limited is higher than 52% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.